论文信息 - Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden - 字舞流文

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden

T. Ciuleanu | J. Vuky | G. Kollia | N. Steeghs | I. Lugowska | M. Tschaika | J. Baden | L. Lupinacci | M. Richardet | R. Slepetis | Ning Huang | Misena Pacius | Anthony Goncalves | M. Schenker | A. Leary | M. Burotto | P. A. Ascierto | J. Delord | Patrick Schoffski | M. Maio | Julieta Grasselli | David S P Tan | Jennifer Friedmann | Somasekhar Konduru | S. V. Vemula | Quyen Duong | Parul Doshi | Massimo Di Nicola